Tonghua Dongbao Pharmaceutical Co., Ltd.SSE: 600867

Announcement on Expected Increase in Performance for 2025

Jan 27, 2026 · Issued by Tonghua Dongbao Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 27, 2026

On 6ix: 6ix.com/news/announcement-on-expected-increase-in-performance-for-2025-48

Announcement on Expected Increase in Performance for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Tonghua Dongbao Pharmaceutical Co., Ltd. on 6ix

Earlier from Tonghua Dongbao Pharmaceutical

Announcement on Appointment of Senior Management MembersJan 16
Announcement on Changing Signing Engagement Partner and Signatory Certified Public Accountant by Audit InstitutionJan 9
Announcement on Resolutions of the 1st Holders' Meeting for Employee Stock Ownership Plan in R&D and Production SystemJan 8
Announcement on the Completion of Non-Trade Stock Transfer under the Employee Stock Ownership Plan for R&D and Production System StaffDec 30, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025Dec 16, 2025

Later from Tonghua Dongbao Pharmaceutical

Announcement on Receiving Decision on Administrative Supervision Measures from Jilin Securities Regulatory BureauJan 31
Rectification Report on Decision on Administrative Supervision Measures from Jilin Office of China Securities Regulatory CommissionFeb 11
Announcement on Progress in Repurchasing Shares through Call AuctionApr 2
Announcement on Implementation Results of Repurchasing Shares through Call Auction and Share ChangesApr 11
Announcement on Implementation of Daily Related Transactions in 2025 and Estimated Daily Related Party Transactions in 2026Apr 20

All Tonghua Dongbao Pharmaceutical news releases

Follow Tonghua Dongbao Pharmaceutical into a list and get an email when it puts out news.

Follow Tonghua Dongbao Pharmaceutical